New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy

Transfusion and Apheresis Science

Volumn 54, Issue 2, 2016, Pages 181-190

  Jodele, Sonata ^a   Dandoy, Christopher E ^a   Myers, Kasiani C ^a   El Bietar, Javier ^a   Nelson, Adam ^a   Wallace, Gregory ^a   Laskin, Benjamin L ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Complement; Eculizumab; Hematopoietic stem cell transplant; TA TMA; Thrombotic microangiopathy

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; CARBOPLATIN; CREATININE; CYSTATIN C; ECULIZUMAB; ETOPOSIDE; FLUDARABINE; HEMOGLOBIN; INFLIXIMAB; LACTATE DEHYDROGENASE; MELPHALAN; NICARDIPINE; PROTEIN; RAPAMYCIN; STEROID;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ANEMIA; ANURIA; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BRONCHOSCOPY; CASE REPORT; CHILD; CLINICAL FEATURE; CREATININE URINE LEVEL; CUSHINGOID SYNDROME; DIARRHEA; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENDOTHELIUM INJURY; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GASTROINTESTINAL ENDOSCOPY; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY; HEMODIALYSIS; HEMOPHAGOCYTIC SYNDROME; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOXEMIA; ILEUS; INTESTINAL BLEEDING; KIDNEY INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG LAVAGE; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEUROBLASTOMA; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PHENOTYPE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROTEIN URINE LEVEL; PROTEINURIA; PULMONARY HYPERTENSION; RELAPSE; RESPIRATORY FAILURE; REVIEW; THORAX RADIOGRAPHY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TREATMENT PLANNING; ADOLESCENT; ADVERSE EFFECTS; ALLOGRAFT; INFANT; THROMBOTIC MICROANGIOPATHIES;

ADOLESCENT; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; THROMBOTIC MICROANGIOPATHIES;

EID: 84964855034     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.04.007     Document Type: Review

References (47)

1. Elsallabi O, Bhatt VR, Dhakal P, Foster KW, Tendulkar KK Hematopoietic stem cell transplant-associated thrombotic microangiopathy. Clin Appl Thromb Hemost 2016, 22:12-20.
2. Keir L, Coward RJ Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol 2011, 26:523-533.
3. Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults. Blood 2014, 124(4):645-653.
4. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:571-575.
5. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007, 92:95-100.
6. Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010, 90:918-926.
7. Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 2014, 29(3):191-204.
8. Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013, 20(4):518-525.
9. Jodele S, Fukuda T, Mizuno K, Vinks AA, Laskin BL, Goebel J, et al. Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016, 22(2):307-315.
10. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006, 82:638-644.
11. Glezerman IG, Jhaveri KD, Watson TH, Edwards AM, Papadopoulos EB, Young JW, et al. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:976-984.
12. Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:515-524.
13. Nehus EJ, Laskin BL, Kathman TI, Bissler JJ Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr Nephrol 2013, 28:453-461.
14. Laskin BL, Goebel J, Davies SM, Khoury JC, Bleesing JJ, Mehta PA, et al. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. Bone Marrow Transplant 2011, 46:682-689.
15. Hingorani S, Gooley T, Pao E, Sandmaier B, McDonald G Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant 2014, 49:403-409.
16. Nakamura Y, Yujiri T, Ando T, Hisano S, Tanizawa Y Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome. Br J Haematol 2007, 136:857-859. author reply 9-60.
17. Hingorani SR, Seidel K, Lindner A, Aneja T, Schoch G, McDonald G Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 2008, 14:1365-1372.
18. Chang A, Hingorani S, Kowalewska J, Flowers ME, Aneja T, Smith KD, et al. Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007, 2:1014-1023.
19. Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008, 85:22-28.
20. Narimatsu H, Kami M, Hara S, Matsumura T, Miyakoshi S, Kusumi E, et al. Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation. Bone Marrow Transplant 2005, 36:517-523.
21. Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant 2004, 33:1143-1150.
22. Yamada-Fujiwara M, Miyamura K, Fujiwara T, Tohmiya Y, Endo K, Onishi Y, et al. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation. Tohoku J Exp Med 2012, 227:31-37.
23. Hewamana S, Austen B, Murray J, Johnson S, Wilson K Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy. Eur J Haematol 2009, 83:277.
24. El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015, 21:1994-2001.
25. Dietrich S, Falk CS, Benner A, Karamustafa S, Hahn E, Andrulis M, et al. Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment. Biol Blood Marrow Transplant 2013, 19:22-27.
26. Andrulis M, Dietrich S, Longerich T, Koschny R, Burian M, Schmitt-Graf A, et al. Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease. Haematologica 2012, 97:1674-1677.
27. Houtchens J, Martin D, Klinger JR Diagnosis and management of pulmonary arterial hypertension. Pulm Med 2011, 2011:845864.
28. Perkowska-Ptasinska A, Sulikowska-Rowinska A, Pazik J, Komuda-Leszek E, Durlik M Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report. Transplant Proc 2006, 38:295-296.
29. Rabinovitch M Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2012, 122:4306-4313.
30. Dandoy C, Davies SM, Hirsch R, Chima RS, Paff Z, Cash M, et al. Abnormal echocardiography seven days after stem cell transplant may be an early indicator of thrombotic microangiopathy. Biol Blood Marrow Transplant 2015, 21(1):113-118.
31. Jodele S, Hirsch R, Laskin B, Davies S, Witte D, Chima R Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013, 19:202-207.
32. Dandoy CE, Hirsch R, Chima R, Davies SM, Jodele S Pulmonary hypertension after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:1546-1556.
33. Lerner D, Dandoy C, Hirsch R, Laskin B, Davies SM, Jodele S Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 2014, 49(6):862-863.
34. Yanagisawa R, Ishii E, Motoki N, Yamazaki S, Morita D, Sakashita K, et al. Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation. Transpl Int 2015, 28:565-574.
35. Cooke KR, Jannin A, Ho V The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14:23-32.
36. Carmona A, Diaz-Ricart M, Palomo M, Molina P, Pino M, Rovira M, et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biol Blood Marrow Transplant 2013, 19:1439-1445.
37. Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, et al. The genetic fingerprint of susceptibility for transplant associated thrombotic microangiopathy. Blood 2016, 127(8):989-996.
38. Cataland SR, Holers VM, Geyer S, Yang S, Wu HM Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP. Blood 2014, 123(24):3733-3738.
39. Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, et al. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2014, 25:55-64.
40. The fourth reporton the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
41. Moulder JE, Cohen EP, Fish BL Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res 2011, 175:29-36.
42. Hingorani S Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant. Pediatr Nephrol 2008, 23:879-888.
43. Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009, 361:1639-1650.
44. Shayani S, Palmer J, Stiller T, Liu X, Thomas SH, Khuu T, et al. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 2013, 19:298-304.
45. Dhakal P, Giri S, Pathak R, Bhatt VR Eculizumab in transplant-associated thrombotic microangiopathy. Clin Appl Thromb Hemost 2015.
46. de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, et al. Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation 2015, 99(9):1953-1959.
47. Kim SS, Patel M, Yum K, Keyzner A Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options. Transfusion 2015, 55:452-458.